Rigel Pharmaceuticals Investor Relations Material

Rigel Pharmaceuticals Inc. is a biotechnology company focused on discovering, developing, and commercializing small-molecule drugs for immune and hematologic disorders, as well as rare diseases. The company’s research and development efforts target critical pathways in the immune system to address conditions with significant unmet medical needs. Rigel also partners with other pharmaceutical companies to advance its therapeutic candidates. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.